You raise some good points the Velocide... What shocks me, is that no one has looked for neurotoxicity in people treated with amphetamines. I mean, it would be hard, you'd have to account for a lot of shit, but still, if amphetamines are neurotoxic, you'd think that'd be a damn good place to look...
Your fourth paragraph raises some interesting questions; MDMA does 'inhibit' the intra-cellular 'vesicular monoamine transporter' (VAT/VMAT). Though it doesn't really inhibit it, as much as compete at it.
It all boils down to definitions. After a single dose of any drug, you're brain is changed; receptors get internalized, electrical singals are modified etc... i.e. not cell death, but function changes... the brain is so plastic, that these must have a long term effect; though just so small it doesn't matter; THOUGH, with drugs that effect glutamate strongly, NMDA antagonists and 5-HT2A agonists, I suspect you will see an effect of those functional changes.
I've never known anyone who abused NMDA antagonists long term (though I hear long term DXMers get preety retarded), but people who take shrooms everyday for months go fucking crazy.
Meanwhile DXM is neuroprotective as hell, its true. It underwent human trials as a post stroke neuroprotectant.
Here's the first link I could find... appropriate seeing as we were talking about MPTP